본문 바로가기
KERD
논문KCI 등재

Cortisol Measurements in Cushing's Syndrome: Immunoassay or Mass Spectrometry?

Gregori Casals|Felicia Alexandra Hanzu
대한진단검사의학회 (Korean Society For Laboratory Medicine)|2020.07|Annals of Laboratory Medicine|제40권 제4호|pp. 285-296|DOI 10.3343/alm.2020.40.4.285

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

SensitivityCortisolMass spectrometryImmunoassay
주제분류병리학

초록

Determination of cortisol levels in the urine (24 hours urine free cortisol), saliva (late-night), or serum (total cortisol after dexamethasone suppression) is recommended to screen for Cushing’s syndrome (CS). This review focuses on the differences between the frequently used cortisol-antibody immunoassay-based methods and the highly specific mass-spectrometry-based methods that are progressively being employed in clinical laboratories for CS screening. The particular characteristics of cortisol metabolism and the lack of specificity of the immunoassays cause marked differences between both methods that are in turn highly dependent on the biological matrix, in which the cortisol is measured. Understanding the origin of these differences is essential for the interpretation of these results. Although cross-reactivity with endogenous steroids leads to grossly inaccurate results of immunoassay measurements of cortisol in the saliva and urine, preliminary evidence suggests that the clinical sensitivity of CS screening using immunoassays may be similar to CS screening using mass spectrometry. However, mass spectrometry offers more accurate results and considerably reduced variation across laboratories, while avoiding false-positive results. Moreover, mass spectrometry can overcome some common diagnostic challenges, such as identification of exogenous corticosteroids or simultaneous assessment of appropriate dexamethasone levels in suppression tests. Further, comprehensive mass spectrometry-based profiling of several steroid metabolites may be useful for discriminating among different subtypes of CS. Finally, this review discusses the main preanalytical factors that could cause variations in cortisol measurements and their influence on the reliability of the results.

Abstract

Determination of cortisol levels in the urine (24 hours urine free cortisol), saliva (late-night), or serum (total cortisol after dexamethasone suppression) is recommended to screen for Cushing’s syndrome (CS). This review focuses on the differences between the frequently used cortisol-antibody immunoassay-based methods and the highly specific mass-spectrometry-based methods that are progressively being employed in clinical laboratories for CS screening. The particular characteristics of cortisol metabolism and the lack of specificity of the immunoassays cause marked differences between both methods that are in turn highly dependent on the biological matrix, in which the cortisol is measured. Understanding the origin of these differences is essential for the interpretation of these results. Although cross-reactivity with endogenous steroids leads to grossly inaccurate results of immunoassay measurements of cortisol in the saliva and urine, preliminary evidence suggests that the clinical sensitivity of CS screening using immunoassays may be similar to CS screening using mass spectrometry. However, mass spectrometry offers more accurate results and considerably reduced variation across laboratories, while avoiding false-positive results. Moreover, mass spectrometry can overcome some common diagnostic challenges, such as identification of exogenous corticosteroids or simultaneous assessment of appropriate dexamethasone levels in suppression tests. Further, comprehensive mass spectrometry-based profiling of several steroid metabolites may be useful for discriminating among different subtypes of CS. Finally, this review discusses the main preanalytical factors that could cause variations in cortisol measurements and their influence on the reliability of the results.

참고문헌 (87)

  1. Lacroix A, "Cushing’s syndrome", Lancet, 386, pp.913~927 (2015)
  2. Clayton RN, "Mortality and morbidity in Cushing’s disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature", J Clin Endocrinol Metab, 96, pp.632~642 (2011)
  3. Neary NM, "Hypercortisolism is associated with increased coronary arterial atherosclerosis : analysis of noninvasive coronary angiography using multidetector computerized tomography", J Clin Endocrinol Metab, 98, pp.2045~2052 (2013)
  4. Loriaux DL, "Diagnosis and differential diagnosis of Cushing’s syndrome", N Engl J Med, 376, pp.1451~1459 (2017)
  5. Pappachan JM, "Cushing’s syndrome : a practical approach to diagnosis and differential diagnoses", J Clin Pathol, 70, pp.350~359 (2017)
  6. Chabre O, "The difficulties of pseudo-Cushing’s syndrome (or ‘non-neoplastic hypercortisolism’)", Ann Endocrinol(Paris), 79, pp.138~145 (2018)
  7. Jung C, "A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum", J Clin Endocrinol Metab, 96, pp.1533~1540 (2011)
  8. Chiodini I, "Clinical review : diagnosis and treatment of subclinical hypercortisolism", J Clin Endocrinol Metab, 96, pp.1223~1236 (2011)
  9. Meinardi JR, "Cyclic Cushing’s syndrome: a clinical challenge", Eur J Endocrinol, 157, pp.245~254 (2007)
  10. Manenschijn L, "A novel tool in the diagnosis and follow-up of (cyclic) Cushing’s syndrome: measurement of long-term cortisol in scalp hair", J Clin Endocrinol Metab, 97, pp.E1836~E1843 (2012)
  11. Hodes A, "Mini-review of hair cortisol concentration for evaluation of Cushing syndrome", Expert Rev Endocrinol Metab, 13, pp.225~231 (2018)
  12. Greff MJE, "Hair cortisol analysis : an update on methodological considerations and clinical applications", Clin Biochem, 63, pp.1~9 (2019)
  13. Juszczak A, "Endotext" (2000), MDText.com, Inc.
  14. Nieman LK, "The diagnosis of Cushing’s syndrome : an Endocrine Society Clinical Practice Guideline", J Clin Endocrinol Metab, 93, pp.1526~1540 (2008)
  15. Arnaldi G, "Diagnosis and complications of Cushing’s syndrome : a consensus statement", J Clin Endocrinol Metab, 88, pp.5593~5602 (2003)
  16. Barbot M, "Second-line tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome", Pituitary, 19, pp.488~495 (2016)
  17. Aranda G, "Long-term remission and recurrence rate in a cohort of Cushing’s disease: the need for long-term follow-up", Pituitary, 18, pp.142~149 (2015)
  18. Yeo KT, "Endotext" (2017), MDText.com, Inc
  19. Deutschbein T, "Measurement of urinary free cortisol by current immunoassays: need for sex-dependent reference ranges to define hypercortisolism", Horm Metab Res, 43, pp.714~719 (2011)
  20. Miki K, "Effect of urine pH, storage time, and temperature on stability of catecholamines, cortisol, and creatinine", Clin Chem, 44, pp.1759~1762 (1998)
  21. Hansen AM, "Seasonal and biological variation of urinary epinephrine, norepinephrine, and cortisol in healthy women", Clin Chim Acta, 309, pp.25~35 (2001)
  22. Pecori Giraldi F, "Variability in laboratory parameters used for management of Cushing’s syndrome", Endocrine, 50, pp.580~589 (2015)
  23. Chan KC, "Diminished urinary free cortisol excretion in patients with moderate and severe renal impairment", Clin Chem, 50, pp.757~759 (2004)
  24. Turpeinen U, "Determination of cortisol in serum, saliva and urine", Best Pract Res Clin Endocrinol Metab, 27, pp.795~801 (2013)
  25. Wood L, "Measurement of urinary free cortisol by tandem mass spectrometry and comparison with results obtained by gas chromatography-mass spectrometry and two commercial immunoassays", Ann Clin Biochem, 45, pp.380~388 (2008)
  26. Aranda G, "Accuracy of immunoassay and mass spectrometry urinary free cortisol in the diagnosis of Cushing’s syndrome", Pituitary, 19, pp.496~502 (2016)
  27. McCann SJ, "Measurement of urinary free cortisol using liquid chromatography-tandem mass spectrometry: comparison with the urine adapted ACS:180 serum cortisol chemiluminescent immunoassay and development of a new reference range", Ann Clin Biochem, 42, pp.112~118 (2005)
  28. Ceccato F, "Screening tests for Cushing’s syndrome: urinary free cortisol role measured by LC-MS", MS, 2015, pp.100, 3856~3861
  29. Ceccato F, "The diagnostic performance of urinary free cortisol is better than the cortisol: cortisone ratio in detecting de novo Cushing’s syndrome: the use of a LC-MS", MS method in routine clinical practice, 2014, pp.171, 1~7
  30. Murphy BE, "How much “UFC” is really cortisol?", Clin Chem, 46, pp.793~794 (2000)
  31. Raff H, "Urine free cortisol in the diagnosis of Cushing’s syndrome: is it worth doing and, if so, how?", J Clin Endocrinol Metab, 100, pp.395~397 (2015)
  32. Oßwald A, "Performance of LC-MS", MS and immunoassay based 24-h urine free cortisol in the diagnosis of Cushing’s syndrome, 2019, pp.190, 193~197
  33. El-Farhan N, "Measuring cortisol in serum, urine and saliva–are our assays good enough?", Ann Clin Biochem, 54, pp.308~322 (2017)
  34. Roberts RF, "Performance characteristics of five automated serum cortisol immunoassays", Clin Biochem, 37, pp.489~493 (2004)
  35. Fink RS, "Hypothalamic-pituitary-adrenal axis function after inhaled corticosteroids : unreliability of urinary free cortisol estimation", J Clin Endocrinol Metab, 87, pp.4541~4546 (2002)
  36. Thynne T, "Factitious Cushing’s syndrome masquerading as Cushing’s disease", Clin Endocrinol (Oxf), 80, pp.328~332 (2014)
  37. Djedovic NK, "Detection of synthetic glucocorticoids by liquid chromatography-tandem mass spectrometry in patients being investigated for Cushing’s syndrome", Ann Clin Biochem, 48, pp.542~549 (2011)
  38. Taylor RL, "Quantitative, highly sensitive liquid chromatography-tandem mass spectrometry method for detection of synthetic corticosteroids", Clin Chem, 50, pp.2345~2352 (2004)
  39. Krone N, "Gas chromatography", mass spectrometry (GC, MS, pp.MS), J Steroid Biochem Mol Biol[DOI]
  40. Marcos J, "Investigation of endogenous corticosteroids profiles in human urine based on liquid chromatography tandem mass spectrometry", Anal Chim Acta, 812, pp.92~104 (2014)
  41. Casals G, "Microwave-assisted derivatization : application to steroid profiling by gas chromatography", mass spectrometry, 2014, pp.960, 8~13
  42. Brossaud J, "Urinary glucocorticoid metabolites: biomarkers to classify adrenal incidentalomas?", Clin Endocrinol (Oxf), 84, pp.236~243 (2016)
  43. Ceccato F, "Diagnostic accuracy of increased urinary cortisol", cortisone ratio to differentiate ACTH-dependent Cushing’s syndrome, 2017, pp.87, 500~507
  44. Kulle AE, "Principles and clinical applications of liquid chromatography–tandem mass spectrometry for the determination of adrenal and gonadal steroid hormones", J Endocrinol Invest, 34, pp.702~708 (2011)
  45. Brossaud J, "LC-MSMS assays of urinary cortisol, a comparison between four in-house assays", Clin Chem Lab Med, 56, pp.1109~1116 (2018)
  46. Carroll T, "Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis", Endocr Pract, 15, pp.335~342 (2009)
  47. Elamin MB, "Accuracy of diagnostic tests for Cushing’s syndrome: a systematic review and metaanalyses", J Clin Endocrinol Metab, 93, pp.1553~1562 (2008)
  48. Raff H, "Bedtime salivary cortisol and cortisone by LC-MS", MS in healthy adult subjects: evaluation of sampling time, 2019, pp.3, 1631~1640
  49. Baid SK, "Radioimmunoassay and tandem mass spectrometry measurement of bedtime salivary cortisol levels: a comparison of assays to establish hypercortisolism", J Clin Endocrinol Metab, 92, pp.3102~3107 (2007)
  50. Casals G, "Day-to-day variation of late-night salivary cortisol in healthy voluntaries", Clin Biochem, 44, pp.665~668 (2011)
  51. Sandouk Z, "Variability of late-night salivary cortisol in Cushing disease: A prospective study", J Clin Endocrinol Metab, 103, pp.983~990 (2018)
  52. Coelli S, "Influence of age, gender and body mass index on late-night salivary cortisol in healthy adults", Clin Chem Lab Med, 55, pp.1954~1961 (2017)
  53. Inder WJ, "Measurement of salivary cortisol in 2012–laboratory techniques and clinical indications", Clin Endocrinol (Oxf), 77, pp.645~651 (2012)
  54. Calvi JL, "Measurement of cortisol in saliva: a comparison of measurement error within and between international academic-research laboratories", BMC Res Notes, 10, pp.479~ (2017)
  55. Deutschbein T, "Salivary cortisol as a diagnostic tool for Cushing’s syndrome and adrenal insufficiency: improved screening by an automatic immunoassay", Eur J Endocrinol, 166, pp.613~618 (2012)
  56. Vogeser M, "Measurement of late-night salivary cortisol with an automated immunoassay system", Clin Chem Lab Med, 44, pp.1441~1445 (2006)
  57. Ceccato F, "The diagnostic accuracy of increased late night salivary cortisol for Cushing’s syndrome : a real-life prospective study", J Endocrinol Invest, 42, pp.327~335 (2019)
  58. Monaghan PJ, "The use of mass spectrometry to improve the diagnosis and the management of the HPA axis", Rev Endocr Metab Disord, 14, pp.143~157 (2013)
  59. Beko G, "Cutoff values of midnight salivary cortisol for the diagnosis of overt hypercortisolism are highly influenced by methods", Clin Chim Acta, 411, pp.364~367 (2010)
  60. Raff H, "Cushing’s syndrome: diagnosis and surveillance using salivary cortisol", Pituitary, 15, pp.64~70 (2012)
  61. Mészáros K, "Diagnostic performance of a newly developed salivary cortisol and cortisone measurement using an LC-MS", MS method with simple and rapid sample preparation, 2018, pp.41, 315~323
  62. Kline GA, "Factitious ACTH-dependent, apparent hypercortisolism: the problem with late-night salivary cortisol measurements collected at home", Clin Endocrinol (Oxf), 87, pp.882~885 (2017)
  63. Raff H, "Measurement of late-night salivary cortisol and cortisone by LC-MS", MS to assess preanalytical sample contamination with topical hydrocortisone, 2012, pp.58, 947~948
  64. Israelsson M, "20α-and 20β-dihydrocortisone may interfere in LC-MS", MS determination of cortisol in saliva and urine, 2018, pp.55, 341~347
  65. Fassnacht M, "Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors", Eur J Endocrinol, 175, pp.G1~G34 (2016)
  66. Lynnette Kaye Nieman, "Recent Updates on the Diagnosis and Management of Cushing's Syndrome", Endocrinology and Metabolism, 33(2), pp.139~146 (2018), 대한내분비학회
  67. Vastbinder M, "The influence of oral contraceptives on overnight 1 mg dexamethasone suppression test", Neth J Med, 74, pp.158~161 (2016)
  68. Meikle AW, "Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone", Clin Endocrinol (Oxf), 16, pp.401~408 (1982)
  69. Hempen C, "Dexamethasone suppression test: development of a method for simultaneous determination of cortisol and dexamethasone in human plasma by liquid chromatography", tandem mass spectrometry, 2012, pp.49, 170~176
  70. Ueland GÅ, "Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test", Eur J Endocrinol, 176, pp.705~713 (2017)
  71. Brixey-McCann R, "Effect of cortisol assay bias on the overnight dexamethasone suppression test: implications for the investigation of Cushing’s syndrome", Endocrine Abstracts, 38, pp.22~ (2015)
  72. Monaghan PJ, "Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11β- hydroxylase inhibitor metyrapone", Ann Clin Biochem, 48, pp.441~446 (2011)
  73. El-Farhan N, "Method-specific serum cortisol responses to the adrenocorticotrophin test: comparison of gas chromatography-mass spectrometry and five automated immunoassays", Clin Endocrinol (Oxf), 78, pp.673~680 (2013)
  74. Masjkur J, "Plasma steroid profiles in subclinical compared with overt adrenal Cushing syndrome", J Clin Endocrinol Metab, 104, pp.4331~4340 (2019)
  75. Eisenhofer G, "Plasma steroid metabolome profiling for diagnosis and subtyping patients with Cushing syndrome", Clin Chem, 64, pp.586~596 (2018)
  76. Raff H, "Late-night salivary cortisol as a screening test for Cushing’s syndrome", J Clin Endocrinol Metab, 83, pp.2681~2686 (1998)
  77. Papanicolaou DA, "Nighttime salivary cortisol: a useful test for the diagnosis of Cushing’s syndrome", J Clin Endocrinol Metab, 87, pp.4515~4521 (2002)
  78. Putignano P, "Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing’s syndrome", J Clin Endocrinol Metab, 88, pp.4153~4157 (2003)
  79. Yaneva M, "Midnight salivary cortisol for the initial diagnosis of Cushing’s syndrome of various causes", J Clin Endocrinol Metab, 89, pp.3345~3351 (2004)
  80. Viardot A, "Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test", J Clin Endocrinol Metab, 90, pp.5730~5736 (2005)
  81. Bukan AP, "The performance and reproducibility of late-night salivary cortisol estimation by enzyme immunoassay for screening Cushing disease", Endocr Pract, 21, pp.158~164 (2015)
  82. Findling JW, "Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing’s disease: 12-month, Phase III pasireotide study", Endocrine, 54, pp.516~523 (2016)
  83. Ambroziak U, "The morning and late-night salivary cortisol ranges for healthy women may be used in pregnancy", Clin Endocrinol (Oxf), 83, pp.774~778 (2015)
  84. Lages AS, "Late-night salivary cortisol: cut-off definition and diagnostic accuracy for Cushing’s syndrome in a Portuguese population", Acta Med Port, 32, pp.381~387 (2019)
  85. Erickson D, "Late-night salivary cortisol for diagnosis of Cushing’s syndrome by liquid chromatography", tandem mass spectrometry assay, 2012, pp.76, 467~472
  86. Palmieri S, "The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism", Eur J Endocrinol, 168, pp.289~296 (2013)
  87. Antonelli G, "Salivary cortisol and cortisone by LC-MS", MS: validation, reference intervals and diagnostic accuracy in Cushing’s syndrome, 2015, pp.451, 247~251

관련 논문AI추천

Comparison of Direct and Extraction Immunoassay Methods With Liquid Chromatography-Tandem Mass Spectrometry Measurement of Urinary Free Cortisol for the Diagnosis of Cushing’s SyndromeCheng Jin, Cheng Xinqi, Fang Jiadan, Hu Yingying, Ma Yichen, Mu Danni, Qiu Ling, Qi Zhihong, Song Ailing, Xia Liangyu, Yu Songlin, Zhang Kui, Zhang Qi, Zhao Fang, Zhu Huijuan대한진단검사의학회 · Annals of Laboratory Medicine2024 · 제44권 제1호Second-Line Tests in the Diagnosis of Adrenocorticotropic Hormone-Dependent HypercortisolismBarbot Mattia, Ceccato Filippo, Pinelli Silvia, Scaroni Carla대한진단검사의학회 · Annals of Laboratory Medicine2021 · 제41권 제6호Diagnosis of cyclic Cushing syndrome using the morning urine free cortisol to creatinine ratio김기전, 김혜수, 이인석, 이종민, 장이선, 최수아대한내과학회 · The Korean Journal of Internal Medicine2016 · 제31권 제1호Simultaneous quantitative analysis of salivary cortisol and cortisone in Korean adults using LC-MS/MS신혜진, 이상후, 임환섭, Kyoung-Ryul Lee, Ravinder J. Singh, Soonho Kwon, Young-Jin Kim생화학분자생물학회 · BMB Reports2010 · 제43권 제7호A Sensitive and Specific Liquid Chromatography-Tandem Mass Spectrometry Assay for Simultaneous Quantification of Salivary Melatonin and Cortisol: Development and Comparison With Immunoassays이수연, Joo Eun Yeon, Oh Hyeonju, Park Hea Ree, Shin Sunghwan대한진단검사의학회 · Annals of Laboratory Medicine2021 · 제41권 제1호Hormone Immunoassay Interference: A 2021 UpdateBrabant Severine, Ghazal Khaldoun, Piketty Marie-Liesse, Prie Dominique대한진단검사의학회 · Annals of Laboratory Medicine2022 · 제42권 제1호

이 간행물의 다른 논문 (11건)

HDL Subclass Analysis in Predicting Metabolic Syndrome in Koreans With High HDL Cholesterol LevelsHanah Kim, Salvatore Di Somma, Hyun Suk Yang, Sun Jong Kim, Sojung Shin, Mina Hurpp. 297-305Determination of Colistin Resistance by Simple Disk Diffusion Test Using Modified Mueller-Hinton AgarDaewon Kim, Jean Damascene Uwizeyimana, Hyunsook Lee, Jung-Hyun Byun, 용동은pp. 306-311Development of an Automated Image Analyzer for Microvessel Density Measurement in Bone Marrow BiopsiesKwang Gi Kim, 공선영, 심효은, Yousun Chung, Seungwon Shin, Ji Yeon Sohn, Dong-eun Lee, Lee Hyewon, Hyeon Seok Eompp. 312-316Comparison Between the SFTS-QS Kit and the PowerChek SFTSV Real-time PCR Kit for the Detection of Severe Fever With Thrombocytopenia Syndrome VirusYoung Kyung Yoon, Nam Yong Lee, 유인영, Hee Jae Huh, Ji-Youn Kimpp. 317-320Emergence of optrA-Mediated Linezolid-Nonsusceptible Enterococcus faecalis in a Tertiary Care HospitalJeonghyun Chang, Mi-Na Kim, Heungsup Sung, Kuenyoul Park, Yun Sil Jeongpp. 321-325
원문 보기